Sagen JV - Search Results

1

GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.

Negahdar M, Aukrust I, Molnes J, Solheim MH, Johansson BB, Sagen JV, Dahl-Jørgensen K, Kulkarni RN, Søvik O, Flatmark T, Njølstad PR, Bjørkhaug L. Negahdar M, et al. Among authors: sagen jv. Mol Cell Endocrinol. 2014 Jan 25;382(1):55-65. doi: 10.1016/j.mce.2013.08.020. Epub 2013 Aug 31. Mol Cell Endocrinol. 2014. PMID: 24001579

2

[Non-insulin dependent diabetes in children and adolescents].

Njølstad PR, Søvik O, Bell GI, Cockburn BN, Følling I, Sagen J. Njølstad PR, et al. Tidsskr Nor Laegeforen. 1998 Mar 10;118(7):1054-7. Tidsskr Nor Laegeforen. 1998. PMID: 9531829 Norwegian.

3

Hyperexcitability to sulphonylurea in MODY3.

Søvik O, Njølstad P, Følling I, Sagen J, Cockburn BN, Bell GI. Søvik O, et al. Diabetologia. 1998 May;41(5):607-8. doi: 10.1007/s001250050956. Diabetologia. 1998. PMID: 9628283 No abstract available.

4

Reduced prevalence of late-diabetic complications in MODY3 with early diagnosis.

Sagen JV, Njølstad PR, Søvik O. Sagen JV, et al. Diabet Med. 2002 Aug;19(8):697-8. doi: 10.1046/j.1464-5491.2002.00688_1.x. Diabet Med. 2002. PMID: 12147154 No abstract available.

5

Hepatocyte nuclear factor-1 alpha gene mutations and diabetes in Norway.

Bjørkhaug L, Sagen JV, Thorsby P, Søvik O, Molven A, Njølstad PR. Bjørkhaug L, et al. Among authors: sagen jv. J Clin Endocrinol Metab. 2003 Feb;88(2):920-31. doi: 10.1210/jc.2002-020945. J Clin Endocrinol Metab. 2003. PMID: 12574234

6

Contributions to the MODY5 phenotype.

Søvik O, Sagen J, Njølstad PR, Nyland H, Myhr KM. Søvik O, et al. J Inherit Metab Dis. 2002 Nov;25(7):597-8. doi: 10.1023/a:1022051609386. J Inherit Metab Dis. 2002. PMID: 12638944 No abstract available.

7

Enlarged nephrons and severe nondiabetic nephropathy in hepatocyte nuclear factor-1beta (HNF-1beta) mutation carriers.

Sagen JV, Bostad L, Njølstad PR, Søvik O. Sagen JV, et al. Kidney Int. 2003 Sep;64(3):793-800. doi: 10.1046/j.1523-1755.2003.00156.x. Kidney Int. 2003. PMID: 12911528 Free article.

8

Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway.

Njølstad PR, Sagen JV, Bjørkhaug L, Odili S, Shehadeh N, Bakry D, Sarici SU, Alpay F, Molnes J, Molven A, Søvik O, Matschinsky FM. Njølstad PR, et al. Among authors: sagen jv. Diabetes. 2003 Nov;52(11):2854-60. doi: 10.2337/diabetes.52.11.2854. Diabetes. 2003. PMID: 14578306

9

Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.

Sagen JV, Raeder H, Hathout E, Shehadeh N, Gudmundsson K, Baevre H, Abuelo D, Phornphutkul C, Molnes J, Bell GI, Gloyn AL, Hattersley AT, Molven A, Søvik O, Njølstad PR. Sagen JV, et al. Diabetes. 2004 Oct;53(10):2713-8. doi: 10.2337/diabetes.53.10.2713. Diabetes. 2004. PMID: 15448106

10

Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1alpha mutation carriers.

Sagen JV, Pearson ER, Johansen A, Spyer G, Søvik O, Pedersen O, Njølstad PR, Hattersley AT, Hansen T. Sagen JV, et al. Diabet Med. 2005 Apr;22(4):406-9. doi: 10.1111/j.1464-5491.2005.01439.x. Diabet Med. 2005. PMID: 15787664

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page